B

Biome Australia Ltd
ASX:BIO

Watchlist Manager
Biome Australia Ltd
ASX:BIO
Watchlist
Price: 0.535 AUD -1.83% Market Closed
Market Cap: 117.2m AUD
Have any thoughts about
Biome Australia Ltd?
Write Note

Biome Australia Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biome Australia Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
B
Biome Australia Ltd
ASX:BIO
Accounts Receivables
AU$2.9m
CAGR 3-Years
57%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Bioxyne Ltd
ASX:BXN
Accounts Receivables
AU$978.4k
CAGR 3-Years
43%
CAGR 5-Years
5%
CAGR 10-Years
20%
McPherson's Ltd
ASX:MCP
Accounts Receivables
AU$24m
CAGR 3-Years
-14%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Star Combo Pharma Ltd
ASX:S66
Accounts Receivables
AU$4.5m
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Elixinol Wellness Ltd
ASX:EXL
Accounts Receivables
AU$1.5m
CAGR 3-Years
14%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Accounts Receivables
$1.7m
CAGR 3-Years
30%
CAGR 5-Years
28%
CAGR 10-Years
N/A
No Stocks Found

Biome Australia Ltd
Glance View

Market Cap
115.1m AUD
Industry
Consumer products

Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-30. The firm licenses, develops and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products include 22 products marketed under three brands, being Activated Probiotics, Activated Nutrients and Activated X Performance. These products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trials.

BIO Intrinsic Value
0.34 AUD
Overvaluation 36%
Intrinsic Value
Price
B

See Also

What is Biome Australia Ltd's Accounts Receivables?
Accounts Receivables
2.9m AUD

Based on the financial report for Jun 30, 2024, Biome Australia Ltd's Accounts Receivables amounts to 2.9m AUD.

What is Biome Australia Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
69%

Over the last year, the Accounts Receivables growth was 99%. The average annual Accounts Receivables growth rates for Biome Australia Ltd have been 57% over the past three years , 69% over the past five years .

Back to Top